five

Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors

收藏
Taylor & Francis Group2023-09-09 更新2026-04-16 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Novel_Strategy_Involving_High-Dose_Chemotherapy_with_Stem_Cell_Rescue_Followed_by_Intrathecal_Topotecan_Maintenance_Therapy_without_Whole-Brain_Irradiation_for_Atypical_Teratoid_Rhabdoid_Tumors/24113794/1
下载链接
链接失效反馈
官方服务:
资源简介:
Atypical teratoid/rhabdoid tumor (AT/RT) is a rare aggressive central nervous system tumor that typically affects children under three years old and has poor survival with a high risk for neurologic deficits. The primary purpose of this study was to successfully treat the disease and delay or avoid whole-brain radiotherapy for children with AT/RT. A retrospective analysis was performed for six children diagnosed with AT/RT and treated with multimodal treatment at a single institute between 2014 and 2020. Furthermore, germline <i>SMARCB1</i> aberrations and <i>MGMT</i> methylation status of the tumors were analyzed. One patient who did not receive a modified IRS-III regimen replaced with ifosphamide, carboplatin, and etoposide (ICE) in induction chemotherapy was excluded from this analysis. Five patients who received ICE therapy were under three years old. After a surgical approach, they received intensive chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation (HDCT/autoPBSCT) followed by intrathecal topotecan maintenance therapy. Three patients underwent single HDCT/autoPBSCT, and the other two received sequential treatment. Two patients with germline <i>SMARCB1</i> aberrations and metastases died of progressive AT/RT or therapy-related malignancy, while 3 with localized tumors without germline <i>SMARCB1</i> aberrations remained alive. One survivor received local radiotherapy only, while the other two did not undergo radiotherapy. All three surviving patients were able to avoid whole-brain radiotherapy. Our results suggest that AT/RT patients with localized tumors without germline <i>SMARCB1</i> aberrations can be rescued with multimodal therapy, including induction therapy containing ICE followed by HDCT/autoPBSCT and intrathecal topotecan maintenance therapy without radiotherapy. Further large-scale studies are necessary to confirm this hypothesis.
提供机构:
Jinnouchi, Takashi; Yokogami, Kiyotaka; Yamashita, Shinji; Takeshima, Hideo; Yamada, Ai; Moritake, Hiroshi; Kinoshita, Mariko; Kamimura, Sachiyo; Azuma, Minako
创建时间:
2023-09-09
二维码
社区交流群
二维码
科研交流群
商业服务